What is the status of clinical trial NCT05886920?

NCT05886920 is currently recruiting. This is a PHASE1 study for advanced solid tumors with mapk pathway mutations sponsored by D3 Bio (Wuxi) Co., Ltd. Status verified from ClinicalTrials.gov.

Live Status Check

NCT05886920 Recruiting Status

Q: Where is NCT05886920 recruiting?

NCT05886920 is recruiting at 3 locations across the United States.

Q: How do I enroll in NCT05886920?

To enroll in NCT05886920, check your eligibility on HelloStudys.com and complete the interest form. A coordinator will contact you about next steps.

Real-time enrollment status for this advanced solid tumors with mapk pathway mutations clinical trial

Current Status

Recruiting

Auto-verified from ClinicalTrials.gov

Checked: August 31, 2026 at 9:40 PM UTC

NCT05886920 Status Summary

NCT Number	NCT05886920
Recruiting Status	Recruiting
Condition	Advanced Solid Tumors With MAPK Pathway Mutations
Phase	PHASE1
Target Enrollment	67 participants
Active Locations	3 sites in the US
Sponsor	D3 Bio (Wuxi) Co., Ltd
Last Updated on CT.gov	August 6, 2026 (3 weeks ago)

About NCT05886920 Enrollment Status

As of August 31, 2026: Clinical trial NCT05886920 is currently recruiting participants. This phase1 study for advanced solid tumors with mapk pathway mutations is actively seeking new participants at 3 locations across the United States. The study is sponsored by D3 Bio (Wuxi) Co., Ltd. This status information is automatically verified from the official ClinicalTrials.gov registry.

Frequently Asked Questions About NCT05886920

Is NCT05886920 still recruiting?

Yes, NCT05886920 is actively recruiting participants as of August 31, 2026. You can check eligibility and apply through HelloStudys.

Where is NCT05886920 recruiting?

This trial is recruiting at 3 locations in the United States. View all available locations on the full study page.

How do I enroll in NCT05886920?

Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.

When was NCT05886920 status last updated?

The official ClinicalTrials.gov record for NCT05886920 was last updated 3 weeks ago (August 6, 2026). HelloStudys verifies this status automatically.

Browse More Advanced Solid Tumors With MAPK Pathway Mutations Trials

Advanced Solid Tumors Trials Alzheimers Disease Trials Atopic Dermatitis Trials Erectile Dysfunction Trials All Conditions →

Ready to Apply?

Check your eligibility for this clinical trial